Jakutiene Eitaute, Grikiniene Jurgita, Vaitkevicius Arunas, Tschaika Marina, Didziapetriene Janina, Stakisaitis Donatas
Vilnius University Children's Hospital, Vilnius, Lithuania.
BMC Pharmacol. 2007 Aug 6;7:9. doi: 10.1186/1471-2210-7-9.
The diuretic effect of valproates and its relation to urinary potassium (K+) and chloride (Cl-) excretion have not yet been investigated, so the aim of this study was to evaluate the influence of a single dose of sodium valproate (NaVPA) on 24-h urinary K+ and Cl- excretion in young adult Wistar rats of both genders. For measurement of K+ in urine, the same animals and samples as in our earlier publication were used (Pharmacology 2005 Nov, 75:111-115). The authors propose a new approach to the pathophysiological mechanisms of NaVPA effect on K+ and Cl- metabolism. Twenty six Wistar rats were examined after a single intragastric administration of 300 mg/kg NaVPA (13 NaVPA-male and 13 NaVPA-female), 28 control intact Wistar rats (14 males and 14 females) were studied as a control group. The 24-h urinary K+, Cl-, creatinine and pH levels were measured.
Total 24-h diuresis and 24-h diuresis per 100 g of body weight were found to be significantly higher in NaVPA-rats of both genders than in rats of the control group (p < 0.05). The data showed NaVPA to enhance 24-h K+ excretion in NaVPA-males and NaVPA-females with significant gender-related differences: 24-h K+ excretion in NaVPA-male rats was significantly higher than in control males (p = 0.003) and NaVPA-female rats (p < 0.001). Regarding the 24-h K+ excretion, NaVPA-female rats did not show a statistically significant difference versus females of the control group (p > 0.05). 24-h urinary K+ excretion per 100 g of body weight in NaVPA-male rats was significantly higher than in control males (p = 0.025). NaVPA enhanced Cl- urinary excretion: 24-h Cl- urinary excretion, 24-h urinary Cl- excretion per 100 g of body weight and the Cl-/creatinine ratio were significantly higher in NaVPA-male and NaVPA-female rats than in gender-matched controls (p < 0.05). 24-h chloriduretic response to NaVPA in male rats was significantly higher than in female rats (p < 0.05).
NaVPA causes kaliuretic and chloriduretic effects with gender-related differences in rats. Further investigations are necessary to elucidate the mechanism of such pharmacological effects of NaVPA.
丙戊酸盐的利尿作用及其与尿钾(K+)和氯(Cl-)排泄的关系尚未得到研究,因此本研究的目的是评估单剂量丙戊酸钠(NaVPA)对成年雌雄Wistar大鼠24小时尿K+和Cl-排泄的影响。为了测量尿中的K+,使用了与我们之前发表的文章相同的动物和样本(《药理学》2005年11月,75:111 - 115)。作者提出了一种新的方法来研究NaVPA对K+和Cl-代谢影响的病理生理机制。26只Wistar大鼠经胃内单次给予300 mg/kg NaVPA(13只NaVPA雄性和13只NaVPA雌性),28只对照未处理的Wistar大鼠(14只雄性和14只雌性)作为对照组进行研究。测量了24小时尿K+、Cl-、肌酐和pH水平。
发现两性NaVPA大鼠的24小时总尿量和每100克体重的24小时尿量均显著高于对照组大鼠(p < 0.05)。数据显示NaVPA可增加NaVPA雄性和雌性大鼠的24小时K+排泄,且存在显著的性别差异:NaVPA雄性大鼠的24小时K+排泄显著高于对照雄性大鼠(p = 0.003)和NaVPA雌性大鼠(p < 0.001)。关于24小时K+排泄,NaVPA雌性大鼠与对照组雌性大鼠相比未显示出统计学显著差异(p > 0.05)。NaVPA雄性大鼠每100克体重的24小时尿K+排泄显著高于对照雄性大鼠(p = 0.025)。NaVPA增加了尿Cl-排泄:NaVPA雄性和雌性大鼠的24小时尿Cl-排泄、每100克体重的24小时尿Cl-排泄以及Cl-/肌酐比值均显著高于性别匹配的对照组(p < 0.05)。雄性大鼠对NaVPA的24小时氯利尿反应显著高于雌性大鼠(p < 0.05)。
NaVPA在大鼠中引起排钾利尿和排氯利尿作用,且存在性别差异。有必要进一步研究以阐明NaVPA这种药理作用的机制。